Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standardized versus individualized growth hormone treatment of short children born small for gestational age
2013-003100-39Phase 4Active
- Sponsor
- Dutch Growth Research Foundation
- Start
- Aug 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of somatropin in growth disorder (2 arms), sponsored by Dutch Growth Research Foundation. Primary endpoints: Adult height standard deviation score (SDS), First-year growth response and 1 more. Started Aug 2013; status: active.
02
Drugs
somatropin
03
Conditions
growth disorder
Beyond the preview
Go deeper on 2013-003100-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003100-39.